* *ADVISORY* *Valerian should be used only by those with difficulty falling asleep and not by those who have difficulty staying asleep. Any medication that has an effect on the central nervous system, including all medicines used for sleep, depression and anxiety, has the potential to interact with valerian. Long-term use for more than 6 weeks has not been studied. Talk with your health care provider about these concerns if you decide to use valerian.
DOSAGE:Dosing recommendations for insomnia are inconsistent, ranging from 400 to 900 mg of extract, taken 30 to 60 minutes before bed. We recommend using the dose suggested on the label.
CONCLUSION:We conclude that while valerian appears promising for the treatment of insomnia, there is not enough evidence for us to support its use for this condition. Patients who took valerian did see improvement in their sleep within a 6-week period. For long term use it is best to consider other treatments. These may include stress management and techniques for improving sleep hygiene, such as regular bedtimes, avoiding naps, moderating alcohol intake, and eliminating caffeine. If you do elect to try it, remember to include it in your list of medications when you visit your doctor and other health care providers.
REFERENCES“Valerian.” ConsumerLab.com. ConsumerLab.com LLC, 2013. 20 October 2013.“Valerian.” Natural Standard –The Authority on Integrative Medicine. Natural Standard, 2013.“Valerian.” Natural Medicines Comprehensive Database. Therapeutic Research Faculty, 2013. 8 November 2013.Bent, S. et al. Valerian for Sleep: A Systematic Review and Meta-Analysis. The American Journal of Medicine (2006) 119, 1005-1012Salter, S., Brownie, S. et al. Treating primary insomnia. Australian Family Physician (2010) 39(6):433-437Fernandez-San-Martin, I. et al. Effectiveness of Valerian on insomnia: A meta-analysis of randomized placebo-controlled trials. Sleep Medicine (2010) 11, 505-511Oxman, A. et al. A Televised, Web-Based Randomised Trial of an Herbal Remedy (Valerian) for Insomnia. PLoS ONE (2007) 2(10): e1040